This is clinically relevant because obesity itself is associated with numerous health conditions that might influence treatment tolerance, including metabolic syndrome, cardiovascular disease, sleep apnea, and hepatic steatosis
If nothing shifts within 23 weeks, its time to revisit dose, delivery method, or stacking options with your provider
So let's play a little game
However, Retatrutide is a triple agonist, potentially offering more effective weight management
I know they feel the same, we have conversations in between meetings, even before we prep, we do you know, kind of go over their stories, and we speak with them
It also can affect anyone at any age, but it is more prevalent in middle-aged or older people